WO2013186300A2 - Assembly for injecting a viscous liquid product - Google Patents
Assembly for injecting a viscous liquid product Download PDFInfo
- Publication number
- WO2013186300A2 WO2013186300A2 PCT/EP2013/062238 EP2013062238W WO2013186300A2 WO 2013186300 A2 WO2013186300 A2 WO 2013186300A2 EP 2013062238 W EP2013062238 W EP 2013062238W WO 2013186300 A2 WO2013186300 A2 WO 2013186300A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- assembly
- downstream
- coupling interface
- upstream
- Prior art date
Links
- 239000012263 liquid product Substances 0.000 title claims description 7
- 238000002347 injection Methods 0.000 claims abstract description 58
- 239000007924 injection Substances 0.000 claims abstract description 58
- 230000008878 coupling Effects 0.000 claims abstract description 52
- 238000010168 coupling process Methods 0.000 claims abstract description 52
- 238000005859 coupling reaction Methods 0.000 claims abstract description 52
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 34
- 238000005086 pumping Methods 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 239000000047 product Substances 0.000 claims description 58
- 239000000463 material Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 abstract description 14
- 239000002872 contrast media Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 238000012546 transfer Methods 0.000 description 9
- 238000004500 asepsis Methods 0.000 description 6
- 239000003570 air Substances 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- PYHRZPFZZDCOPH-QXGOIDDHSA-N (S)-amphetamine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C[C@H](N)CC1=CC=CC=C1.C[C@H](N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-QXGOIDDHSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 239000012080 ambient air Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M2039/0009—Assemblies therefor designed for particular applications, e.g. contrast or saline injection, suction or irrigation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3334—Measuring or controlling the flow rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/04—Tools for specific apparatus
- A61M2209/045—Tools for specific apparatus for filling, e.g. for filling reservoirs
Definitions
- the present invention relates to the general technical field of the administration of a product, in particular liquid or viscous, to a patient, for example parenterally, possibly from a flexible bag.
- the present invention relates to an assembly for medical use for injecting liquid or viscous product into the human body.
- the contrast injection operation requires the transfer of the contrast product between a container containing this contrast medium and the patient.
- This transfer is implemented using a medical use assembly comprising an injection line - such as a tube connected to the container on the one hand and the patient on the other hand - for the transfer of the contrast medium between the container and the patient.
- the injection operation comprises:
- a step of transferring the contrast product between the container and the patient a step of transferring the contrast product between the container and the patient.
- an autonomous device is used to fill the container from a power source.
- EP 0 648 513 proposes a set for medical use comprising:
- an injection line for transferring the product to be injected between the container and the patient
- This set has the advantage of limiting the number of connections / disconnections required for the implementation of the step of filling the container.
- the filling step can be implemented according to three different techniques: i) a gravity filling of the power source:
- a disadvantage of this technique is that the filling time of the container is very long, which induces a long duration of the injection operation.
- the following two filling techniques are intended to reduce the filling time: ii) suction filling of the product contained in the feed source:
- a disadvantage of this technique is that it can degrade the quality of the contrast product. Indeed, during suction filling, particularly with the aid of a syringe, a significant depression is created in the filling line and the water component of the contrast product can pass into the gas phase. This phenomenon is amplified in the case where the contrast product is heated.
- a disadvantage of this technique is that it can be implemented only with a rigid power source. Moreover, this technique can be implemented at a very low pressure (less than one bar) to limit the risk of leakage. Finally, this technique does not make it possible to determine the quantity of product transferred between the primary source and the container.
- An object of the present invention is to provide a set for medical use to overcome at least one of the aforementioned drawbacks.
- the invention proposes an assembly for medical use for injecting a patient with a liquid or viscous product, such as a contrast product, characterized in that the assembly comprises:
- an injection line for transferring the product to be injected between a container and the patient, said injection line comprising an upstream tubular part, a downstream tubular part and a threshold non-return valve on the downstream tubular part, said threshold check valve allowing the liquid product to pass from the container to the patient,
- a filling line for transferring the product to be injected between a supply source and the container via the upstream tubular part, said filling line being connected to the injection line between the upstream and downstream tubular parts and comprising a non-return valve allowing the passage of the liquid product from the supply source to the container,
- the filling line comprises a pipe upstream of the coupling interface and a pipe downstream of the coupling interface, the hardness of the pipe upstream of the coupling interface being greater than the hardness of the pipe in downstream of the coupling interface;
- the hardness of the tubing upstream of the coupling interface is equal to or greater than 70 ShA (the Shore hardness, expressed in Shore A or ShA, corresponds to a unit of measurement of the hardness of elastomers or of certain plastics very well known to those skilled in the art and recognized by the international standards ISO 868 and 7619, ASTM D 2240 and DIN 53505);
- the filling line comprises a pipe upstream of the coupling interface and a pipe downstream of the coupling interface, the inside diameter of the pipe upstream of the coupling interface being greater than the inside diameter the tubular part downstream of the injection line;
- the inside diameter of the tubing upstream of the coupling interface is between 3 and 6 millimeters
- the filling line comprises a pipe upstream of the coupling interface and a pipe downstream of the coupling interface, the hardness of the pipe downstream of the pumping unit being less than the hardness of the tubular part downstream of the injection line;
- the shore hardness of the pipe downstream of the pumping unit is between 60 and 80 ShA;
- the filling line comprises a pipe upstream of the coupling interface and a pipe downstream of the coupling interface, the diameter of the pipe downstream of the coupling interface being greater than the diameter of the downstream tubular part.
- the assembly for medical use further comprises the container, said container being connected to the injection line prior to its use;
- the container is a pocket composed of two sheets of material superimposed and welded at their periphery to define a space for containing the liquid or viscous product;
- the assembly for medical use further comprises an irremovable connection between the container and the injection line.
- the assembly for medical use can be used in an injector of the type described in the French patent application No. FR 1255530 filed in the name of the company MEDEX.
- the container of the assembly for medical use is a pocket with superimposed sheets and welded at their periphery and a pipe for the passage of the liquid or viscous product.
- This pocket is intended to be positioned in the injector so that the pipe of the pocket is the element of the pocket farthest from the ground, so that a possible volume of air contained in the pocket is in contact with the when the bag is filled with liquid or viscous product.
- FIG. 1 illustrates an embodiment of a set for medical use for the injection of a liquid or viscous product to a patient.
- an injection operation generally comprises two phases:
- the container used during an injection operation is generally empty to allow the user to use it with different types and / or concentrations of products to be injected.
- the injection assembly for medical use described below allows the implementation of these two phases (i.e. filling / administration) during an injection operation.
- FIG. 1 there is illustrated an embodiment of the assembly for medical use for injecting a patient with a liquid or viscous product, such as a contrast product.
- the assembly for medical use comprises an injection line 1 and a filling line 2.
- the injection line 1 allows the transfer of the product to be injected between a container 3 and the patient.
- the filling line 2 allows the transfer of the product to be injected between a primary supply source 4 and the container 3.
- a filling line 2 improves the asepsis of the injection operation, the number of connections / disconnections necessary to allow the filling of the container 3 being limited.
- the assembly for medical use also comprises a coupling interface 26 on the filling line 2.
- This coupling interface 26 is used to couple a pumping unit 22 to the filling line of the assembly for medical use.
- the pumping unit 22 may be a peristaltic pump - composed of rollers and a motor - and the coupling interface 26 may be a flexible hose intended to come into contact with the rollers of the peristaltic pump.
- the diameter, the thickness and the elasticity of the flexible pipe are adapted to make it possible to improve the coupling of the filling line 2 with the pumping unit 22.
- the pumping interface may be a pipe:
- a coupling interface 26 integrated with the filling line 2 makes it possible to prevent direct contact of the pumping unit 22 with the injectable solution. Thus, it is no longer necessary to clean the pumping unit 22 with each replacement of the power source, and especially when the power sources successively used contain products of different natures.
- the asepsis of the filling operation is also improved, since the pumping unit 22 is not directly connected to the assembly for medical use, but is coupled thereto via the interface of FIG. coupling 26.
- the injection line 1 comprises an upstream tubular part 12, a downstream tubular part 1 1 and a connector 14 with three inputs - in particular of Y or T type connector - between the upstream and downstream tubular parts 1 1, 12.
- the connector 14 with three inputs makes it possible to connect the filling line 2 to the injection line 1.
- One of the ends of the injection line 1 comprises a connecting element - such as a "luer lock" - intended to be connected to an injection conduit 15.
- This injection conduit 15 is, for example, a catheter, a hypodermic or intravenous needle or any other type of injection conduit known to those skilled in the art.
- the other end of the injection line 1 is connected to the container 3 for containing the product to be injected into the patient.
- the container 3 can be integrated into the assembly for medical use.
- the assembly for medical use comprises the container 3.
- the container 3 is pre-connected to the injection line 1 during the manufacture of the assembly for medical use.
- the user does not need to connect the container 3 to the injection line 1 when using the assembly for medical use.
- the assembly for medical use further comprises an irremovable connection 31 between the container 3 and the injection line 1. This limits the risk of disconnection between the container 3 and the injection line 1.
- the term "irremovable connection” means an element (for example a weld, a glue, or any other element known to those skilled in the art) permitting a permanent assembly of two parts so that these two pieces can no longer be separated from one another, the assembly of the two parts by this element being performed prior to the use of the assembly, especially during the manufacture of the assembly.
- the container 3 intended to contain the product to be injected may be:
- a syringe composed of a cylindrical body in which is housed a piston covered with an elastomer seal on its front face, said piston being able to move in translation between a retracted position (where the syringe is empty) and an extended position (where the syringe is filled with the product to be injected),
- a flexible pouch composed for example of two superimposed sheets and welded at their periphery to define a space intended to contain the liquid or viscous product
- a container 3 of the pocket type will be preferred, in particular to improve the asepsis of the assembly for medical use.
- the internal portion of cylindrical body located at the rear of the elastomeric seal is in contact with the ambient air, which, when the piston moves between the deployed positions and retracted, can decrease asepsis.
- the injection line 1 may also comprise a non-return valve 13 on the downstream tubular part 1 1.
- This non-return valve 13 allows the passage of liquid in a single direction, namely from the container 3 to the patient.
- the nonreturn valve 13 may have a high opening threshold (i.e. greater than 500 mbar). This avoids the risk of transfer of liquid product directly to the patient (without passing through the container) during the filling phase.
- the non-return valve 13 may also have a higher opening threshold, in particular greater than 1.5 bar (ideally greater than or equal to 2 bar) for allow the use of the assembly for medical use in an injector of the type described in French Patent Application No. FR 1255530 in the name of the company MEDEX.
- Such an injector comprises a housing consisting of two articulated half-shells in order to allow the relative displacement of the half-shells relative to one another between:
- One of the half-shells comprises a bladder - called “active bladder” - deformable variable volume under the action of a hydraulic power source supplying said bladder with hydraulic fluid.
- the other of the half-shells includes a deformable cushion at constant volume - called “passive cushion”.
- the opening threshold of the threshold valve is greater than 1.5 bar (and preferably greater than or equal to 2 bar) makes it possible to ensure good veneering of the container against the bladder and the cushion. This plating is necessary to allow such an injector to control:
- the operating principle of such an injector is as follows: the bladder is filled with hydraulic fluid so that the walls of the container are pressed against the walls of the cushion and the bladder .
- the introduction of a given amount of hydraulic fluid into the bladder induces the expulsion of the same amount of contrast medium out of the container.
- one milliliter of incompressible fluid introduced into the bladder mechanically "flushes" one milliliter of contrast material out of the container 3.
- the operating principle of such an injector is as follows: the bladder is filled with hydraulic fluid so that the container walls are pressed against the cushion and bladder.
- the introduction of contrast material into the container induces an increase in its volume which tends to apply a pushing force on the cushion and the bladder. This force induces the expulsion of hydraulic fluid from the bladder.
- the introduction of a given amount of contrast medium into the container induces the expulsion of the same amount of hydraulic fluid out of the bladder. .
- the opening threshold of the threshold valve is greater than 1.5 bar (and preferably greater than or equal to 2 bar) makes it possible to guarantee a good plating of the container 3 on the bladder and the cushion even before the slightest flow of contrast product out of the container, the flow of contrast product out of the container requiring a minimum pressure of 1.5 bar in the container.
- the filling line 2 comprises a pipe 21 upstream of the coupling interface 26 and a pipe 23 downstream of the coupling interface 26.
- the length of the tubing 21 upstream of the coupling interface 26 is between 400 and 800 millimeters in order to limit the pressure drops between the coupling interface 26 and the power source 4 when suction of the fluid for filling the container 3.
- the inside diameter of the pipe 21 upstream of the coupling interface 26 may be greater than the inside diameter of the downstream tubular part 1 1 of the injection line 1.
- the internal diameter of the tubing 21 upstream of the pumping unit 22 may be between 3 and 6 millimeters.
- the hardness of the tubing 21 upstream of the coupling interface 26 may be greater than the hardness of the tubing 23 downstream of the coupling interface 26.
- the hardness of the tubing 21 upstream of the coupling interface 26 may be equal to or greater than 70 ShA.
- the fact of having a tubing 21 with a hardness equal to or greater than 70 ShA makes it possible to avoid collapsing thereof during the suction of the fluid for filling the container 3.
- the hardness of the tubing is selected less than 90 ShA to facilitate its winding during packaging and facilitate its handling by the operator during installation on the injector.
- the hardness of the pipe 23 downstream of the coupling interface 26 may be chosen to be less than the hardness of the downstream tubular portion 11 of the injection line 1.
- the Shore A hardness of the tubing 23 downstream of the coupling interface 26 may be between 60 and 80 ShA.
- the hardness of the tubing 23 is less than or equal to 80 ShA enables the filling line 2 to absorb the pulsations possibly generated by the pumping unit 22 in order to limit the risks of overpressure in the overall use. medical, overpressure may induce product leakage to the patient through the high-threshold check valve 13 of the injection line 1.
- the diameter of the pipe 23 downstream of the coupling interface 26 may be chosen to be greater than the diameter of the downstream tubular portion 11 of the injection line 1.
- the diameter of the tubing 23 downstream of the coupling interface 26 may be between 3 and 6 millimeters.
- the filling line 2 may also include a check valve 25 allowing the passage of liquid in a single direction, namely from the primary supply source 4 to the container 3.
- a check valve 25 allows to isolate the filling line 2 after completion of the filling phase, and this without requiring manipulation of the user prior to the implementation of the phase of administration of the product to the patient.
- the filling line 2 may comprise a bubble scavenger 24 such as a dropper chamber between the primary supply source 4 and the container 3.
- This bubble scavenger 24 makes it possible to drive the air between the source of the fuel. primary feed 4 and the container 3.
- the operating principle of the assembly for medical use described above is as follows: during the implementation of a product injection operation to a patient, the user exits the assembly for medical use of its packaging. It connects:
- the pumping unit 22 is actuated to fill the container 3 with the product to be injected.
- the product to be injected moves between the primary supply source 4 and the container 3.
- the high-threshold check valve 13 prevents the passage of the product in the downstream tubular part 1 1 of the injection line 1 so that to avoid any risk of inadvertent output of product to be injected to the free end of the injection line 1 during the filling phase.
- the container 3 fills with product to be injected.
- the user interrupts the filling phase to implement the phase of administering the product to the patient having previously purged the air initially contained in the filling lines 2 and injection 1.
- the container 3 is then pressurized - for example by using a bag injector or a syringe pusher device - to induce the movement of the product between the container 3 and the patient.
- the non-return valve 25 of the filling line 2 prevents the passage of the product between the container 3 and the primary supply source 4.
- the product passes through the injection conduit 15 and enters the patient.
- the administration phase is interrupted either automatically or by user actuation.
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112014031106A BR112014031106A2 (en) | 2012-06-13 | 2013-06-13 | liquid or viscous product injection set |
CN201380031176.7A CN104582756B (en) | 2012-06-13 | 2013-06-13 | For injecting the component of viscose liquid products |
MX2014015303A MX359778B (en) | 2012-06-13 | 2013-06-13 | Assembly for injecting a viscous liquid product. |
KR1020157000686A KR102188891B1 (en) | 2012-06-13 | 2013-06-13 | Assembly for injecting a viscous liquid product |
EP13728211.7A EP2861276B1 (en) | 2012-06-13 | 2013-06-13 | Assembly for injecting a viscous liquid product |
PL13728211T PL2861276T4 (en) | 2012-06-13 | 2013-06-13 | Assembly for injecting a viscous liquid product |
ES13728211T ES2714501T3 (en) | 2012-06-13 | 2013-06-13 | Injection set of liquid and viscous products |
US14/406,962 US10099006B2 (en) | 2012-06-13 | 2013-06-13 | Assembly for injecting a viscous liquid product |
FR1455479A FR3005581B1 (en) | 2012-06-13 | 2014-06-16 | CONNECTION ASSEMBLY FOR A DEVICE FOR INJECTING A LIQUID CONTAINED IN A POCKET PRESENTED BETWEEN TWO HALF-SHELLS |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261659288P | 2012-06-13 | 2012-06-13 | |
FR1255530 | 2012-06-13 | ||
FR1255530A FR2991881B1 (en) | 2012-06-13 | 2012-06-13 | DEVICE FOR INJECTING A LIQUID PRODUCT COMPRISING TWO MOBILE HALF-SHELLS IN ROTATION IN RELATION TO EACH OTHER |
US61/659,288 | 2012-06-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013186300A2 true WO2013186300A2 (en) | 2013-12-19 |
WO2013186300A3 WO2013186300A3 (en) | 2014-03-27 |
Family
ID=48607280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/062238 WO2013186300A2 (en) | 2012-06-13 | 2013-06-13 | Assembly for injecting a viscous liquid product |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3005581B1 (en) |
WO (1) | WO2013186300A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113398377A (en) * | 2015-08-28 | 2021-09-17 | 克里斯医疗系统股份有限公司 | Flow sensor system including transmission connection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1255530A (en) | 1960-01-29 | 1961-03-10 | Photocolorimeter | |
EP0648513A1 (en) | 1993-10-19 | 1995-04-19 | Medex | Medical injection device |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA726230B (en) * | 1971-09-28 | 1973-05-30 | Bestnu Eng Ltd | Intravenous fluids administration apparatus |
US3888239A (en) * | 1974-06-21 | 1975-06-10 | Morton K Rubinstein | Fluid injection system |
IL69431A (en) * | 1983-08-04 | 1987-12-31 | Omikron Scient Ltd | Liquid delivery system particularly useful as an implantable micro-pump for delivering insulin or other drugs |
US5078683A (en) * | 1990-05-04 | 1992-01-07 | Block Medical, Inc. | Programmable infusion system |
US5165874A (en) * | 1990-05-04 | 1992-11-24 | Block Medical, Inc. | Disposable infusion apparatus and peristaltic pump for use therewith |
US5348539A (en) * | 1993-06-29 | 1994-09-20 | Glenn Herskowitz | Infusion pump for use with prepackaged IV bags |
EP1258262A3 (en) * | 1993-10-28 | 2002-12-18 | Medrad, Inc. | Total system for contrast delivery |
FR2717085B1 (en) * | 1994-03-11 | 1996-07-12 | Medex Sa | Method for injecting medical liquid and its implementation device. |
US6099502A (en) * | 1995-04-20 | 2000-08-08 | Acist Medical Systems, Inc. | Dual port syringe |
US6554791B1 (en) * | 1999-09-29 | 2003-04-29 | Smisson-Cartledge Biomedical, Llc | Rapid infusion system |
AUPR867901A0 (en) * | 2001-11-05 | 2001-11-29 | University of Newcastel Research Associates Limited, The | 'Liquid dispenser' |
WO2005072666A1 (en) * | 2002-10-11 | 2005-08-11 | Medical Solutions, Inc. | Method and apparatus for controlling temperature of infused liquids |
FR2850027B1 (en) * | 2003-01-21 | 2005-09-16 | Medex Sa | DEVICE FOR INJECTING MEDICAL LIQUID |
US8954354B2 (en) * | 2007-05-02 | 2015-02-10 | Carefusion 303, Inc. | Automated intravenous fluid container delivery device and system |
US8579859B2 (en) * | 2009-12-26 | 2013-11-12 | Board Of Regents, The University Of Texas System | Fluid balance monitoring system with fluid infusion pump for medical treatment |
US20110301539A1 (en) * | 2010-06-08 | 2011-12-08 | Rickard Matthew J A | Fill and purge system for a drug reservoir |
-
2013
- 2013-06-13 WO PCT/EP2013/062238 patent/WO2013186300A2/en active Application Filing
-
2014
- 2014-06-16 FR FR1455479A patent/FR3005581B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1255530A (en) | 1960-01-29 | 1961-03-10 | Photocolorimeter | |
EP0648513A1 (en) | 1993-10-19 | 1995-04-19 | Medex | Medical injection device |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113398377A (en) * | 2015-08-28 | 2021-09-17 | 克里斯医疗系统股份有限公司 | Flow sensor system including transmission connection |
CN113398377B (en) * | 2015-08-28 | 2023-05-02 | 克里斯医疗系统股份有限公司 | Flow sensor system including a transmission connection |
Also Published As
Publication number | Publication date |
---|---|
FR3005581B1 (en) | 2019-11-22 |
FR3005581A1 (en) | 2014-11-21 |
WO2013186300A3 (en) | 2014-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2861276B1 (en) | Assembly for injecting a viscous liquid product | |
EP0852152B1 (en) | Medical liquid injection device | |
EP2296733B1 (en) | Device for injecting fluid for medical use | |
EP0973565B1 (en) | Medical device for injecting liquid | |
FR2988006A1 (en) | SECURE LIQUID TRANSFER ASSEMBLY FOR MEDICAL USE | |
FR2913200A1 (en) | NEEDLE PROTECTION DEVICE | |
WO2016166346A1 (en) | Medical valve, kit comprising such a valve, and method for preparing a mixture or an emulsion | |
FR3001393A1 (en) | IMPROVED MEDICAL CONNECTOR | |
FR3034998A1 (en) | MEDICAL VALVE, KIT COMPRISING SUCH FAUCET AND METHOD OF PREPARING MIXTURE OR EMULSION. | |
FR2717085A1 (en) | Method of injecting medical liquid and its implementation device. | |
EP0648513B1 (en) | Medical injection device | |
WO2013186300A2 (en) | Assembly for injecting a viscous liquid product | |
FR3027220A1 (en) | ASSEMBLY FOR STORING MEDICAL USE PRODUCTS | |
FR2931684A1 (en) | INFUSION LINE FOR THE ADMINISTRATION OF MEDICAL TREATMENT LIQUIDS, SUCH AS CHEMOTHERAPY PRODUCTS, TO A PATIENT, AND METHOD OF USING SUCH A LINE OF INFUSION | |
EP2928541B1 (en) | Assembly for medical use for administering a product to a patient | |
WO2008009786A1 (en) | Needleless injection device with double stopper with low pressure profiles | |
WO2014096643A1 (en) | Infusion system for administering a solution and rinsing of said system | |
FR3017301A1 (en) | DEVICE FOR CLEANING, TREATING AND DISINFECTING HEARING AND NASAL PIPES | |
FR3077497A1 (en) | DEVICE FOR ADMINISTERING MULTIPLE MEDICINAL LIQUIDS TO A PATIENT | |
FR2672803A1 (en) | Device for injecting medicaments in liquid phase | |
WO2019012224A1 (en) | Infusion system for administering a solution and rinsing of said system | |
EP3716898A1 (en) | Occlusion collar and implantable occlusion system comprising such a collar | |
FR3061655A1 (en) | DEVICE FOR THE EXTENDED PREPARATION OF A QUANTITY OF STERILE FLUID | |
FR2764808A1 (en) | Pipe for transporting dialysis liquid, especially in peritoneal dialysis perforation element, with penetrable stopper and base plate, in simple, effective design |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13728211 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14406962 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2014/015303 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013728211 Country of ref document: EP |
|
ENP | Entry into the national phase in: |
Ref document number: 20157000686 Country of ref document: KR Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014031106 Country of ref document: BR |
|
ENP | Entry into the national phase in: |
Ref document number: 112014031106 Country of ref document: BR Kind code of ref document: A2 Effective date: 20141211 |